Substituted heterocyclic compound containing alpha-ketone framework, and use thereof
AssigneeChina Pharmaceutical University
InventorsJinxin Wang, Lili Li, Tao Meng, Yanguo Shang, Qingjing Hao, Yihe Jia
Life of this patent
Estimating the term…
Loading patent…
AssigneeChina Pharmaceutical University
InventorsJinxin Wang, Lili Li, Tao Meng, Yanguo Shang, Qingjing Hao, Yihe Jia
Estimating the term…
Disclosed in the present invention are a substituted heterocyclic compound containing an α-ketone framework, and the use thereof, which relate to the field of medicinal chemistry. Specifically disclosed are a substituted heterocyclic compound containing an α-ketone framework, or a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing these compounds, and the medical use thereof, and in particular, the use thereof as a fatty acid amide hydrolase (FAAH) inhibitor in the preparation of a drug for preventing or treating FAAH-related diseases, comprising inflammatory diseases, rheumatoid arthritis, hepatitis, hepatic fibrosis, autoimmune disease, pain, depression, pain and depression comorbidity, autism, social anxiety disorder, Tourette's syndrome, neurode-generative diseases, anxiety and post-traumatic stress disorder (PTSD), cannabinoid use disorders, drug withdrawal and anti-tumor treatment.
A compound as shown in formula I or a pharmaceutically acceptable salt thereof:
(canceled)
A compound or a pharmaceutically acceptable salt thereof, selected from:
Dependencies are inferred from the claim text.